The stock of BeiGene Ltd ADR (ONC) has seen a 11.27% increase in the past week, with a 9.01% gain in the past month, and a -14.87% decrease in the past quarter. The volatility ratio for the week is 4.53%, and the volatility levels for the past 30 days are at 3.07% for ONC. The simple moving average for the past 20 days is 11.14% for ONC’s stock, with a 11.92% simple moving average for the past 200 days.
Is It Worth Investing in BeiGene Ltd ADR (NASDAQ: ONC) Right Now?
The 36-month beta value for ONC is at 0.62. Analysts have varying views on the stock, with 13 analysts rating it as a “buy,” 7 rating it as “overweight,” 2 as “hold,” and 0 as “sell.”
The public float for ONC is 96.27M, and currently, shorts hold a 1.36% of that float. The average trading volume for ONC on January 15, 2025 was 354.10K shares.
ONC) stock’s latest price update
The stock of BeiGene Ltd ADR (NASDAQ: ONC) has increased by 8.87 when compared to last closing price of 184.61.Despite this, the company has seen a gain of 11.27% in its stock price over the last five trading days.
Analysts’ Opinion of ONC
Many brokerage firms have already submitted their reports for ONC stocks, with Morgan Stanley repeating the rating for ONC by listing it as a “Overweight.” The predicted price for ONC in the upcoming period, according to Morgan Stanley is $300 based on the research report published on December 03, 2024 of the previous year 2024.
JMP Securities, on the other hand, stated in their research note that they expect to see ONC reach a price target of $288. The rating they have provided for ONC stocks is “Mkt Outperform” according to the report published on September 18th, 2024.
JP Morgan gave a rating of “Overweight” to ONC, setting the target price at $185 in the report published on February 06th of the previous year.
ONC Trading at 5.04% from the 50-Day Moving Average
After a stumble in the market that brought ONC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -19.01% of loss for the given period.
Volatility was left at 3.07%, however, over the last 30 days, the volatility rate increased by 4.53%, as shares surge +11.49% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -2.43% lower at present.
During the last 5 trading sessions, ONC rose by +11.27%, which changed the moving average for the period of 200-days by +29.60% in comparison to the 20-day moving average, which settled at $180.85. In addition, BeiGene Ltd ADR saw 8.81% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ONC starting from Wang Xiaodong, who sale 41,760 shares at the price of $176.50 back on Jan 07 ’25. After this action, Wang Xiaodong now owns 0 shares of BeiGene Ltd ADR, valued at $7,370,515 using the latest closing price.
XIAODONG WANG, the Director of BeiGene Ltd ADR, proposed sale 125,280 shares at $180.64 during a trade that took place back on Jan 07 ’25, which means that XIAODONG WANG is holding shares at $22,630,579 based on the most recent closing price.
Stock Fundamentals for ONC
Equity return is now at value -23.90, with -15.15 for asset returns.
The liquidity ratio also appears to be rather interesting for investors as it stands at 1.93.
Conclusion
In conclusion, BeiGene Ltd ADR (ONC) has had a better performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
